Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Intravenous Veletri (epoprostenol) injection could be efficient in treating Raynaud’s phenomenon, a literature review published in the journal Annals of Pharmacotherapy has shown. In addition, according to the study, ... Read more
A radiopharmaceutical technique can be used as an objective tool to diagnose Raynaud’s phenomenon (RP) and differentiate between primary and secondary RP, according to a study published in the ... Read more
Thenar and hypothenar hammer syndromes and Raynaud’s phenomenon can be successfully treated with iloprost injection according to a case study conducted by a team of researchers from Whales and ... Read more
A case study reported in the medical journal Oxford Medical Case Reports emphasizes the complexity of undifferentiated connective tissue diseases (UCTD), which correspond to a large spectrum of autoimmune ... Read more
Rituxan (rituximab) treatment may be effective in eliminating the symptoms of Raynaud’s Disease according to a case study reported by researchers in Saudi Arabia. ... Read more